Drinking coffee can decrease risk of heart failure: Study ANI | Updated: Feb 13, 2021 18:50 IST
Washington [US], February 13 (ANI): Good news for all the coffee lovers out there! A clinical study drove by three renowned teams of researchers claimed that regular consumption of coffee can reduce the risk of heart failure.
The findings published in American Heart Association, however, found that drinking decaffeinated coffee did not have the same benefit and may be associated with an increased risk for heart failure. There is not yet enough clear evidence to recommend increasing coffee consumption to decrease the risk of heart disease with the same strength and certainty as stopping smoking, losing weight, or exercising.
Cheers, coffee lovers! Drinking coffee regularly can reduce risk of heart failure, shows study
Research has shown that caffeine also can be dangerous if consumed in excesPremium
4 min read
. Updated: 13 Feb 2021, 07:26 PM IST ANI
In all three studies, people who reported drinking one or more cups of caffeinated coffee had an associated decreased long-term heart failure risk
Share Via
Read Full Story
Good news for all the coffee lovers out there! A clinical study drove by three renowned teams of researchers claimed that regular consumption of coffee can reduce the risk of heart failure.
The findings published in American Heart Association, however, found that drinking decaffeinated coffee did not have the same benefit and may be associated with an increased risk for heart failure. There is not yet enough clear evidence to recommend increasing coffee consumption to decrease the risk of heart disease with the same strength and certainty as stopping smoking, losing weight, or e
New anti-obesity medication almost twice as effective as most currently approved weight-loss drugs
‘By far the most effective drug intervention we have seen for weight management’
Effective anti-obesity medication could help limit the need for surgery.
A new anti-obesity medication was shown to be almost twice as effective at helping individuals lose weight than some of the current weight-loss drugs on the market, according to a new landmark study conducted at Northwestern Medicine and other institutions.
The drug, semaglutide, taken once a week at 2.4 mg, works by suppressing appetite centers in the brain to reduce hunger and calorie intake. It could be a gamechanger for those who struggle with obesity, which impacts more than 40% of adults in the U.S. Obesity is associated with multiple complications such as type 2 diabetes, hypertension, heart disease, arthritis, sleep apnea, some forms of cancer and decreased life expectancy.
A new weight-loss drug is almost twice as effective as current medications, clinical trial results show, and experts say it could revolutionize the treatment of obesity. Overweight and obese people lost an average 15% of their body weight.